Ryvu Therapeutics zooCancer therapeuticsRyvu Therapeutics extends cashflow to consolidate pipelineKrakow-based oncology specialist Ryvu Therapeutics zoo today announced a strategic reorganisation that will extend Ryvu’s cash runway to H2/2026 to focus on accelerating three ongoing RVU120 clinical … more ➔
CSUElectionsNew German Chancellor wants a strong EuropeWith a 7.7% lead, the incoming Christian Democrat Chancellor Friedrich Merz has put the radical right-wing AfD in its place. Before forming a government in Germany, Merz emphasised that Germany wants … more ➔
EG 427NeurologyFrench EG 427 bags €27m in Series B financingFrench targeted DNA gene therapy specialist EG427 has closed a €27m Series B financing co-led by VC investor Andera Partners and BPI France to initiate Phase I testing of a Herpes Simplex Virus 1 (nrHSV-1) … more ➔
wikipedia - AnypodetosPartnershipLindis Biotech selects Celonic Group for commercial manufacturing of catumaxomabLINDIS Biotech GmbH has selected Swiss Celonic Group to manufacture its recently EU-approved malignant ascites treatment catumaxomab for commercial supply. more ➔
adobe-Stock.comCHONCHANOK PHOTOCultivated ProteinCultivated B solves fetal bovine serum problemGerman-Canadian food tech specialist The Cultivated B reports that it has identified a small molecule that can replace bovine fibroblast growth factor (bFGF) in the production of cell-based meat with … more ➔
Yves Callewaert4P MedicinenaturalX secures €100m to fuel the future of consumer health in EuropeThe new fund supports of NaturalX, which has its first closing at €100m, supports proactive healthcare, filling a market gap as consumers take control of their own health journey. more ➔
PX GroupBioleachingBRAIN Biotech partners with PX Group in microbial gold recyclingGerman BRAIN Biotech AG and the Switzerland’s PX Group will extend its partnership within the framework of the PX Urban Mining Initiative. The extension builds on previous work, which focused on providing … more ➔
Axplora GroupCDMOAxplora Group announces €50m expansion of GLP-1 manufacturing siteGerman API and antibody drug conjugate (ADC) CDMO Axplora Group GmbH has announced an investment of €50m in its Mourenx site in Southwest France, securing its position as a key player in the fight … more ➔
adobe stock - Monty RNA modalitiesEthris GmbH bags US$5m from CEPIOslo-based Coalition for Epidemic Preparedness Innovations (CEPI) has granted US$5m to RNA formulation specialis Ethris to support studies that demonstrate spray-dried RNA vaccines remain stable at … more ➔
adobe stock - pkproject TransformationThe European Alliance for the Bioeconomy wants to bring back economic growthNow that US President Donald Trump has loudly announced his intention to withdraw from the Paris climate targets and refocus the US economy on fossil fuel production, Europe, which is still a leader … more ➔